{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:48:55Z","timestamp":1781614135581,"version":"3.54.5"},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["NO1-CM-42216, CA21765, and CA108786"],"award-info":[{"award-number":["NO1-CM-42216, CA21765, and CA108786"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Developmental Therapeutics Program (DTP)","award":["NSC 750854"],"award-info":[{"award-number":["NSC 750854"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1002\/pbc.25826","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T13:56:03Z","timestamp":1448373363000},"page":"443-450","source":"Crossref","is-referenced-by-count":2,"title":["Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program"],"prefix":"10.1002","volume":"63","author":[{"given":"Richard","family":"Gorlick","sequence":"first","affiliation":[{"name":"The Children's Hospital at Montefiore; Bronx New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Anders","family":"Kolb","sequence":"additional","affiliation":[{"name":"A.I. duPont Hospital for Children; Wilmington Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Keir","sequence":"additional","affiliation":[{"name":"Duke University Medical Center; Durham North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Maris","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia; University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lock","sequence":"additional","affiliation":[{"name":"Children's Cancer Institute of Australia for Medical Research; University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Carol","sequence":"additional","affiliation":[{"name":"Children's Cancer Institute of Australia for Medical Research; University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Patrick","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center; Lubbock Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min H.","family":"Kang","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center; Lubbock Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Billups","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital; Memphis Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Collins","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Program (DTP); NCI, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dias","family":"Kurmashev","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital; Columbus Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raushan T.","family":"Kurmasheva","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital; Columbus Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Houghton","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital; Columbus Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm A.","family":"Smith","sequence":"additional","affiliation":[{"name":"NCI; Cancer Therapy Evaluation Program; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"10.1002\/pbc.25826-BIB0001|pbc25826-cit-0001","first-page":"4489A","article-title":"5\u2019-Sulfamoyl purines are highly active in many xenografts of human solid tumors via oral, intravenous, and intraperitoneal routes of delivery","author":"Hollingshead","year":"2013","journal-title":"Proc AACR"},{"key":"10.1002\/pbc.25826-BIB0002|pbc25826-cit-0002","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1021\/bi00800a007","article-title":"Inhibition of protein synthesis by 5\u2032-sulfamoyladenosine","volume":"10","author":"Bloch","year":"1971","journal-title":"Biochemistry"},{"key":"10.1002\/pbc.25826-BIB0003|pbc25826-cit-0003","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/1535-7163.MCT-04-0331","article-title":"A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations","volume":"6","author":"Frgala","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pbc.25826-BIB0004|pbc25826-cit-0004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pbc.22801","article-title":"National Cancer Institute Pediatric Preclinical Testing Program: Model description for in vitro cytotoxicity testing","volume":"56","author":"Kang","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25826-BIB0005|pbc25826-cit-0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.21078","article-title":"The Pediatric Preclinical Testing Program: Description of models and early testing results","volume":"49","author":"Houghton","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25826-BIB0006|pbc25826-cit-0006","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood-2003-08-2911","article-title":"Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies","volume":"103","author":"Liem","year":"2004","journal-title":"Blood"},{"key":"10.1002\/pbc.25826-BIB0007|pbc25826-cit-0007","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/pbc.25611","article-title":"Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the Pediatric Preclinical Testing Program","volume":"62","author":"Reynolds","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25826-BIB0008|pbc25826-cit-0008","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/pbc.24989","article-title":"Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the Pediatric Preclinical Testing Program","volume":"61","author":"Kang","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25826-BIB0009|pbc25826-cit-0009","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/pbc.22355","article-title":"Evaluation of cytarabine against Ewing sarcoma xenografts by the Pediatric Preclinical Testing Program","volume":"55","author":"Houghton","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25826-BIB0010|pbc25826-cit-0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/med.20021","article-title":"Sulfamates and their therapeutic potential","volume":"25","author":"Winum","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1002\/pbc.25826-BIB0011|pbc25826-cit-0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","article-title":"Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: The NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ","volume":"37","author":"Brownell","year":"2010","journal-title":"Mol Cell"},{"key":"10.1002\/pbc.25826-BIB0012|pbc25826-cit-0012","doi-asserted-by":"crossref","first-page":"40867","DOI":"10.1074\/jbc.M111.279984","article-title":"Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25826","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.25826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T10:20:49Z","timestamp":1625394049000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25826"}},"subtitle":["Testing of NSC 750854, a Novel Purine Analog"],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25826","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}